본문 바로가기
KERD
논문KCI 등재

Recent advances in extracellular vesicles for therapeutic cargo delivery

Hyo In Kim|Park Jinbong|Zhu Yin|Wang Xiaoyun|Han Yohan|Zhang Duo
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2024.12|Experimental and Molecular Medicine|제56권 |pp. 836-849|DOI 10.1038/s12276-024-01201-6

3

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Exosomes, which are nanosized vesicles secreted by cells, are attracting increasing interest in the field of biomedical research due to their unique properties, including biocompatibility, cargo loading capacity, and deep tissue penetration. They serve as natural signaling agents in intercellular communication, and their inherent ability to carry proteins, lipids, and nucleic acids endows them with remarkable therapeutic potential. Thus, exosomes can be exploited for diverse therapeutic applications, including chemotherapy, gene therapy, and photothermal therapy. Moreover, their capacity for homotypic targeting and self-recognition provides opportunities for personalized medicine. Despite their advantages as novel therapeutic agents, there are several challenges in optimizing cargo loading efficiency and structural stability and in defining exosome origins. Future research should include the development of large-scale, quality-controllable production methods, the refinement of drug loading strategies, and extensive in vivo studies and clinical trials. Despite the unresolved difficulties, the use of exosomes as efficient, stable, and safe therapeutic delivery systems is an interesting area in biomedical research. Therefore, this review describes exosomes and summarizes cutting-edge studies published in high-impact journals that have introduced novel or enhanced therapeutic effects using exosomes as a drug delivery system in the past 2 years. We provide an informative overview of the current state of exosome research, highlighting the unique properties and therapeutic applications of exosomes. We also emphasize challenges and future directions, underscoring the importance of addressing key issues in the field. With this review, we encourage researchers to further develop exosome-based drugs for clinical application, as such drugs may be among the most promising next-generation therapeutics.

Abstract

Exosomes, which are nanosized vesicles secreted by cells, are attracting increasing interest in the field of biomedical research due to their unique properties, including biocompatibility, cargo loading capacity, and deep tissue penetration. They serve as natural signaling agents in intercellular communication, and their inherent ability to carry proteins, lipids, and nucleic acids endows them with remarkable therapeutic potential. Thus, exosomes can be exploited for diverse therapeutic applications, including chemotherapy, gene therapy, and photothermal therapy. Moreover, their capacity for homotypic targeting and self-recognition provides opportunities for personalized medicine. Despite their advantages as novel therapeutic agents, there are several challenges in optimizing cargo loading efficiency and structural stability and in defining exosome origins. Future research should include the development of large-scale, quality-controllable production methods, the refinement of drug loading strategies, and extensive in vivo studies and clinical trials. Despite the unresolved difficulties, the use of exosomes as efficient, stable, and safe therapeutic delivery systems is an interesting area in biomedical research. Therefore, this review describes exosomes and summarizes cutting-edge studies published in high-impact journals that have introduced novel or enhanced therapeutic effects using exosomes as a drug delivery system in the past 2 years. We provide an informative overview of the current state of exosome research, highlighting the unique properties and therapeutic applications of exosomes. We also emphasize challenges and future directions, underscoring the importance of addressing key issues in the field. With this review, we encourage researchers to further develop exosome-based drugs for clinical application, as such drugs may be among the most promising next-generation therapeutics.

참고문헌 (117)

  1. Din, F. U., "Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors", Int. J. Nanomed, 12, pp.7291~7309 (2017)
  2. Domingues, C., "Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology", ACS Nano, 16, pp.9994~10041 (2022)
  3. Yang, F., "Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases", Front. Pharmacol, 13, pp.999404~ (2022)
  4. Alshammari, B. H., "Organic and inorganic nanomaterials : fabrication, properties and applications", RSC Adv, 13, pp.13735~13785 (2023)
  5. Egbuna, C., "Toxicity of nanoparticles in biomedical application : nanotox icology", J. Toxicol, 2021, pp.9954443~ (2021)
  6. Herrmann, I. K., "Extracellular vesicles as a next generation drug delivery platform", Nat. Nanotechnol, 16, pp.748~759 (2021)
  7. Kim, J., "Plant-derived exosome-like nanoparticles and their therapeutic activities", Asian J. Pharm. Sci, 17, pp.53~69 (2022)
  8. Chen, H., "Exosomes, a new star for targeted delivery", Front. Cell Dev. Biol, 9, pp.751079~ (2021)
  9. Ortega, A., "Exosomes as drug delivery systems: endogenous nanovehicles for treatment of systemic lupus erythemato sus", Pharmaceutics, 13 (2020)[DOI]
  10. Han, Y., "Overview and update on methods for cargo loading into extra cellular vesicles", Processes, 9 (2021)[DOI]
  11. Jeppesen, D. K., "Extracellular vesicles and nanoparticles : emerging complexities", Trends Cell Biol, 33, pp.667~681 (2023)
  12. Willms, E., "Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression", Front. Immunol, 9, pp.738~ (2018)
  13. Butler, J. T., "Extracellular vesicles in the hemato poietic microenvironment", Haematologica, 103, pp.382~394 (2018)
  14. EL Andaloussi, S., "Extracellular vesicles : biology and emerging therapeutic opportunities", Nat. Rev. Drug Discov, 12, pp.347~357 (2013)
  15. Liangsupree, T., "Modern isolation and separation techniques for extracellular vesicles", J. Chromatogr. A, 1636, pp.461773~ (2021)
  16. Thery, C., "Minimal information for studies of extracellular vesicles 2018(MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines", J. Extracell. Vesicles, 7, pp.1535750~ (2018)
  17. Witwer, K. W., "Extracellular vesicles or exosomes? On primacy, pre cision, and popularity influencing a choice of nomenclature", J. Extracell. Vesicles, 8, pp.1648167~ (2019)
  18. Minciacchi, V. R., "Extracellular vesicles in cancer:exosomes, microvesicles and the emerging role of large oncosomes", Semin. Cell Dev. Biol, 40, pp.41~51 (2015)
  19. Grant, B. D., "Pathways and mechanisms of endocytic recycling", Nat. Rev. Mol. Cell Biol, 10, pp.597~608 (2009)
  20. Xie, S., "Current knowledge on exosome biogenesis, cargo sorting mechanism and therapeutic implications", Membranes, 12 (2022)[DOI]
  21. Tian, T., "Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery", J. Biol. Chem, 289, pp.22258~22267 (2014)
  22. Nolte-‘t Hoen, E., "Extracellular vesicles and viruses: are they close relatives?", Proc. Natl Acad. Sci. USA, 113, pp.9155~9161 (2016)
  23. Mulcahy, L. A., "Routes and mechanisms of extracellular vesicle uptake", J. Extracell. Vesicles (2014)[DOI]
  24. Joshi, B. S., "Endocytosis of extracellular vesicles and release of their cargo from endosomes", ACS Nano, 14, pp.4444~4455 (2020)
  25. Polanco, J. C., "Exosomes induce endoly sosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol", Acta Neuropathol, 141, pp.235~256 (2021)
  26. Purushothaman, A., "Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions", J. Biol. Chem, 291, pp.1652~1663 (2016)
  27. Hazawa, M., "Radiation increases the cellular uptake of exosomes through CD29", CD81 complex formation, 2014, pp.446, 1165~1171
  28. Prada, I., "Binding and fusion of extracellular vesicles to the plasma membrane of their cell targets", Int. J. Mol. Sci, 17 (2016)[DOI]
  29. Krylova, S. V., "The machinery of exosomes: biogenesis, release, and uptake", Int. J. Mol. Sci, 24 (2023)[DOI]
  30. Cecchin, R., "Extracellular vesicles : the next generation in gene therapy delivery", Mol. Ther, 31, pp.1225~1230 (2023)
  31. Liang, Y., "Cell-derived nanovesicle-mediated drug delivery to the brain : principles and strategies for vesicle engineering", Mol. Ther, 31, pp.1207~1224 (2023)
  32. Luan, X., "Engineering exosomes as refined biological nanoplatforms for drug delivery", Acta Pharmacol. Sin, 38, pp.754~763 (2017)
  33. Gorshkov, A., "Exosomes as natural nano carriers for RNA-based therapy and prophylaxis", Nanomaterials, 12 (2022)[DOI]
  34. Leader, B., "Protein therapeutics : a summary and pharmacological classification", Nat. Rev. Drug Discov, 7, pp.21~39 (2008)
  35. Mitchell, M. J., "Engineering precision nanoparticles for drug delivery", Nat. Rev. Drug Discov, 20, pp.101~124 (2021)
  36. Cao, Z., "Encapsulation of nano-bortezomib in apoptotic stem cell-derived vesicles for the treatment of multiple myeloma", Small, pp.e2301748~ (2023)[DOI]
  37. Lu, J., "Rejuvenation of tendon stem", progenitor cells for functional tendon regeneration through platelet-derived exosomes loaded with recombinant Yap1, 2023, pp.161, 80~99
  38. Banach, M., "Structure of the hydrophobic core determines the 3D protein structure-verification by single mutation proteins", Biomolecules, 10 (2020)[DOI]
  39. Kalinowska, B., "Is the hydrophobic core a universal structural element in proteins?", J. Mol. Model, 23, pp.205~ (2017)
  40. Jiao, Y., "Tumor cell-derived extracellular vesicles for breast cancer specific delivery of therapeutic P53", J. Control Release, 349, pp.606~616 (2022)
  41. Liu, C., "An inhalable hybrid biomimetic nanoplatform for sequential drug release and remodeling lung immune homeostasis in acute lung injury treat ment", ACS Nano, 17, pp.11626~11644 (2023)
  42. Yim, N., "Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module", Nat. Commun, 7, pp.12277~ (2016)
  43. Han, Y., "Extracellular vesicle-encapsulated CC16 as novel nanotherapeutics for treatment of acute lung injury", Mol. Ther, 31, pp.1346~1364 (2023)
  44. Nie, M., "Bioadhesive microcarriers encapsulated with IL-27 high expressive MSC extracellular vesicles for inflam matory bowel disease treatment", Adv. Sci, 10, pp.e2303349~ (2023)
  45. Jung, J. W., "Liver-originated small extracellular vesicles with TM4SF5 target brown adipose tissue for homeostatic glucose clearance", J. Extracell Vesicles, 11, pp.e12262~ (2022)
  46. Salazar-Puerta, A. I., "Engineered extracellular vesicles derived from dermal f ibroblasts attenuate inflammation in a murine model of acute lung injury", Adv. Mater, 35, pp.e2210579~ (2023)
  47. Gao, L., "Wnt3a-loaded extracellular vesicles promote alveolar epithelial regeneration after lung injury", Adv. Sci, 10, pp.e2206606~ (2023)
  48. Liu, W., "Development of allergic rhinitis immunotherapy using antigen-loaded small extracellular vesicles", J. Control Release, 345, pp.433~442 (2022)
  49. Wang, L., "Engineered cytokine-primed extracellular vesicles with high PD L1 expression ameliorate type 1 diabetes", Small, pp.e2301019~ (2023)[DOI]
  50. Liu, X., "Kidney tubular epithelial cells control interstitial fibroblast fate by releasing TNFAIP8-encapsulated exosomes", Cell Death Dis, 14, pp.672~ (2023)
  51. Zhou, X., "Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy", J. Control Release, 357, pp.1~19 (2023)
  52. Milbank, E., "Small extracellular vesicle targeting of hypothalamic AMPKal pha1 promotes weight loss in leptin receptor deficient mice", Metabolism, 139, pp.155350~ (2023)
  53. Ramasamy, T., "Smart nanocarriers for the delivery of nucleic acid-based therapeutics : a comprehensive review", Biotechnol. J, 16, pp.e1900408~ (2021)
  54. Lv, H., "Toxicity of cationic lipids and cationic polymers in gene delivery", J. Control Release, 114, pp.100~109 (2006)
  55. Lam, J. K., "siRNA versus miRNA as ther apeutics for gene silencing", Mol. Ther. Nucleic Acids, 4, pp.e252~ (2015)
  56. Sun, Y., "In vivo self-assembled small RNA targets H19 lncRNA for the treatment of colorectal cancer", J. Control Release, 358, pp.142~160 (2023)
  57. Lu, W., "Engineered NF-kappaB siRNA-encapsulating exosomes as a mod ality for therapy of skin lesions", Front. Immunol, 14, pp.1109381~ (2023)
  58. Rong, Y., "Engineered extracellular vesicles for delivery of siRNA promoting targeted repair of traumatic spinal cord injury", Bioact. Mater, 23, pp.328~342 (2023)
  59. Respaud, R., "Effect of formulation on the stability and aerosol performance of a nebulized antibody", MAbs, 6, pp.1347~1355 (2014)
  60. Elhissi, A. M., "Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures", Int. J. Pharm, 334, pp.62~70 (2007)
  61. Han, Y., "Nebulization of extracellular vesicles : a promising small RNA delivery approach for lung diseases", J. Control Release, 352, pp.556~569 (2022)
  62. Bontempi, G., "Restoration of WT1", miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells, 2022, pp.13, 965~
  63. Bheri, S., "Customized loading of microRNA-126 to small extracellular vesicle-derived vehicles improves cardiac function after myocardial infarction", ACS Nano, 17, pp.19613~19624 (2023)
  64. Elkhoury, K., "Hybrid extracellular vesicles-liposome incorporated advanced bioink to deliver microRNA", Biofabrication, 14 (2022)[DOI]
  65. Hade, M. D., "An effective peptide-based platform for efficient exosomal loading and cellular delivery of a microRNA", ACS Appl. Mater. Interfaces, 15, pp.3851~3866 (2023)
  66. Yin, Z., "Injectable hyperbranched PEG crosslinked hyaluronan hydrogel microparticles containing mir-99a-3p modified subcutaneous ADSCs-derived exosomes was beneficial for long-term treatment of osteoarthritis", Mater. Today Bio, 23, pp.100813~ (2023)
  67. Adamus, T., "Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells", Mol. Ther. Nucleic Acids, 27, pp.611~620 (2022)
  68. Xing, Y., "Efficient delivery of GSDMD-N mRNA by engineered extracellular vesicles induces pyroptosis for enhanced immunotherapy", Small, 19, pp.e2204031~ (2023)
  69. Mei, R., ""All-in-One"exosome engineering strategy for effective therapy of familial hypercholesterolemia", ACS Appl. Mater. Interfaces, 14, pp.50626~50636 (2022)
  70. Yang, Z., "Improved extracellular vesicle-based mRNA delivery for familial hypercholesterolemia treatment", Theranostics, 13, pp.3467~3479 (2023)
  71. Yang, Z., "Large-scale generation of functional mRNA-encapsulating exo somes via cellular nanoporation", Nat. Biomed. Eng, 4, pp.69~83 (2020)
  72. You, Y., "Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy", Nat. Biomed. Eng, 7, pp.887~900 (2023)
  73. Zhang, L., "Targeted elimination of senescent cells by engineered extra cellular vesicles attenuates atherosclerosis in ApoE(-", -)mice with minimal side effects, 2023, pp.13, 5114~5129
  74. Wu, S., "Therapeutic m(6)A eraser ALKBH5 mRNA-loaded exosome-liposome hybrid nanoparticles inhibit progression of colorectal cancer in preclinical tumor models", ACS Nano, 17, pp.11838~11854 (2023)
  75. Camoes, S. P., "3D-MSCs A151 ODN-loaded exosomes are immunomodu latory and reveal a proteomic cargo that sustains wound resolution", J. Adv. Res, 41, pp.113~128 (2022)
  76. He, F., "Exosome-mediated delivery of RBP-J decoy oligodeoxynucleotides ameliorates hepatic fibrosis in mice", Theranostics, 12, pp.1816~1828 (2022)
  77. Huang, X., "Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy", J. Control Release, 343, pp.107~117 (2022)
  78. Born, L. J., "HOTAIR-loaded mesenchymal stem", stromal cell extracellular vesicles enhance angiogenesis and wound healing, 2022, pp.11, e2002070~
  79. Fan, L., "Exosome-based mitochondrial delivery of circRNA mSCAR alleviates sepsis by orchestrating macrophage activation", Adv. Sci, 10, pp.e2205692~ (2023)
  80. Li, X., "Extracellular vesicle-encapsulated adeno-associated viruses for therapeutic gene delivery to the heart", Circulation, 148, pp.405~425 (2023)
  81. Whitley, J. A., "Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing", J. Extracell Vesicles, 12, pp.e12343~ (2023)
  82. Liu, X., "Engineered extracellular vesicle-delivered CRISPR", Cas9 for radio therapy sensitization of glioblastoma, 2023, pp.17, 16432~16447
  83. Stranford, D. M., "Genetically encoding multiple functionalities into extra cellular vesicles for the targeted delivery of biologics to T cells", Nat. Biomed. Eng (2023)[DOI]
  84. "FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease" (2023)[URL]
  85. Reddy, S. K., "Small extracellular vesicle-loaded bevacizumab reduces the frequency of intravitreal injection required for diabetic retinopathy", Theranostics, 13, pp.2241~2255 (2023)
  86. Zhou, Y., "Extracellular vesicles encapsulated with caspase-1 inhibitor ameliorate experimental autoimmune myasthenia gravis through targeting macrophages", J. Control Release, 364, pp.458~472 (2023)
  87. Iyaswamy, A., "Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer’s disease", Signal Transduct. Target Ther, 8, pp.404~ (2023)
  88. Chen, L., "Exosomes as drug carriers in anti-cancer therapy", Front. Cell Dev. Biol, 10, pp.728616~ (2022)
  89. Kang, C., "Harnessing small extracellular vesicles for pro-oxidant delivery : novel approach for drug-sensitive and resistant cancer therapy", J. Control Release, 365, pp.286~300 (2023)
  90. Rehman, F. U., "Heme oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy", J. Control Release, 345, pp.696~708 (2022)
  91. Zhu, Z., "Specific anti-glioma targeted-delivery strategy of engineered small extracellular vesicles dual-functionalised by Angiopep-2 and TAT peptides", J. Extracell Vesicles, 11, pp.e12255~ (2022)
  92. Kim, Y. K., "Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy", J. Control Release, 351, pp.727~738 (2022)
  93. Al Faruque, H., "Enhanced effect of autologous EVs delivering paclitaxel in pancreatic cancer", J. Control Release, 347, pp.330~346 (2022)
  94. Tang, L., "Extracellular vesicles-derived hybrid nanoplatforms for amplified CD47 blockade-based cancer immunotherapy", Adv. Mater, pp.e2303835~ (2023)[DOI]
  95. Guo, R., "Chlorin e6-loaded goat milk-derived extracellular vesicles for Cerenkov luminescence-induced photodynamic therapy", Eur. J. Nucl. Med. Mol. Imaging, 50, pp.508~524 (2023)
  96. Nguyen Cao, T. G., "Bioreducible exosomes encapsulating glycolysis inhi bitors potentiate mitochondria-targeted sonodynamic cancer therapy via cancer-targeted drug release and cellular energy depletion", Biomaterials, 301, pp.122242~ (2023)
  97. Nguyen Cao, T. G., "Brain endothelial cell-derived extracellular vesicles with a mitochondria-targeting photosensitizer effectively treat glioblastoma by hijacking the blood-brain barrier", Acta Pharm. Sin. B, 13, pp.3834~3848 (2023)
  98. Nguyen Cao, T. G., "Mitochondria-targeting sonosensitizer-loaded extra cellular vesicles for chemo-sonodynamic therapy", J. Control Release, 354, pp.651~663 (2023)
  99. Nguyen Cao, T. G., "Engineered extracellular vesicle-based sonotheranostics for dual stimuli-sensitive drug release and photoacoustic imaging-guided chemo-sonodynamic cancer therapy", Theranostics, 12, pp.1247~1266 (2022)
  100. Ji, P., "Modular hydrogel vaccine for programmable and coordinate elici tation of cancer immunotherapy", Adv. Sci, 10, pp.e2301789~ (2023)
  101. Karimi, A., "Herbal versus synthetic drugs; beliefs and facts", J. Nephropharmacol, 4, pp.27~30 (2015)
  102. Zheng, X., "Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia", J. Control Release, 353, pp.675~684 (2023)
  103. Gong, L., "CD44-targeting drug delivery system of exosomes loading for sythiaside A combats liver fibrosis via regulating NLRP3-mediated pyroptosis", Adv. Healthc. Mater, 12, pp.e2202228~ (2023)
  104. Yerneni, S. S., "Skin-targeted delivery of extracellular vesicle-encapsulated curcumin using dissolvable microneedle arrays", Acta Biomater, 149, pp.198~212 (2022)
  105. Gong, L., "An off-the-shelf small extracellular vesicle nanomedicine for tumor targeting therapy", J. Control Release, 364, pp.672~686 (2023)
  106. Yang, J., "Ultra-efficient radio-immunotherapy for reprogramming the hypoxic and immunosuppressive tumor microenvironment with durable innate immune memory", Biomaterials, 302, pp.122303~ (2023)
  107. Huang, R., "Plant exosomes fused with engineered mesenchymal stem cell derived nanovesicles for synergistic therapy of autoimmune skin disorders", J. Extracell Vesicles, 12, pp.e12361~ (2023)
  108. Huang, X., "Current and prospective strategies for advancing the targeted delivery of CRISPR", Cas system via extracellular vesicles, 2023, pp.21, 184~
  109. Gurung, S., "The exosome journey : from biogenesis to uptake and intracellular signalling", Cell Commun. Signal, 19, pp.47~ (2021)
  110. Ngan, S. C., "pSILAC-based determination of cellular protein sorting into extracellular vesicles", Methods Mol. Biol, 2603, pp.43~58 (2023)
  111. Han, L., "Removing the stumbling block of exosome applications in clinical and translational medicine : expand production and improve accuracy", Stem Cell Res. Ther, 14, pp.57~ (2023)
  112. Zhang, T., "CRISPR-Cas12a powered hybrid nanoparticle for extracellular vesicle aggregation and in-situ microRNA detection", Biosens. Bioelectron, 245, pp.115856~ (2024)
  113. Reynolds, D. E., "Single extracellular vesicle analysis using droplet microfluidics", Methods Mol. Biol, 2689, pp.211~220 (2023)
  114. Meng, S., "MiR-141-3p-functionalized exosomes loaded in dissolvable microneedle arrays for hypertrophic scar treatment", Small, pp.e2305374~ (2023)[DOI]
  115. Popowski, K. D., "Inhalable dry powder mRNA vaccines based on extra cellular vesicles", Matter, 5, pp.2960~2974 (2022)
  116. He, J., "Exosomal targeting and its potential clinical application", Drug Deliv. Transl. Res, 12, pp.2385~2402 (2022)
  117. Whiteside, T. L., "Tumor-derived exosomes and their role in cancer progression", Adv. Clin. Chem, 74, pp.103~141 (2016)

관련 논문AI추천

Extracellular vesicles as novel carriers for therapeutic molecules임남빈, 최철희생화학분자생물학회 · BMB Reports2016 · 제49권 제11호In vivo exosome imaging: applications of diverse visualization techniquesHye-Lin Kim, Hyeonah Kim, Hyun Chul Jo, Jangwoo Lee, Jiho Rhim, Jinbong Park, Juhyeong Jeon, Kyung Oh Jung, Seongje Hong, Siyeon Rhee, Yoon Hee Chung생화학분자생물학회 · BMB Reports2025 · 제58권 제8호Extracellular vesicles as emerging intercellular communicasomes고용송, 김오연, 윤예진생화학분자생물학회 · BMB Reports2014 · 제47권 제10호Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer채영찬, Lee Yu Jin, Shin Kyeong Jin생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 Therapeutic exosomes for various human diseases: Special issue of BMB Reports in 2022최철희생화학분자생물학회 · BMB Reports2022 · 제55권 제1호Mesenchymal Stem Cell-derived Exosomes: Applications in Cell-free Therapy김진관, 허준석대한임상검사과학회 · 대한임상검사과학회지2018 · 제50권 제4호

이 간행물의 다른 논문 (218건)

Big data and deep learning for RNA biologyJeon Hyeonseong, Baek Daehyun, Hwang Hyeonseo, Yeo Nagyeongpp. 1-29RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinomaXu Yanan, Ke Shanjia, Lu Shounan, Bai Miaoyu, Yu Hongjun, Yin Bing, Wang Chaoqun, Feng Zhigang, Li Zihao, Huang Jingjing, Li Xinglong, Qian Baolin, Hua Yongliang, Fu Yao, Sun Bei, Wu Yaohua, Ma Yongpp. 1-14Molecular mechanisms of circular RNA translationKim Yoon Ki, Hwang Hyun Jungpp. 1-9The m6A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolismKim Ho, Yun Hye Jin, 이종호, Lee Su Bin, Kim Seok-Ho, Park Yun-Yong, Park Su Hwan, Ju Jin-Sung, Woo Hyunmin, Győrffy Balázs, Kim Eun-jeong, Han Hee Dong, Eyun Seong-ilpp. 1-15Neuron type-specific optogenetic stimulation for differential stroke recovery in chronic capsular infarctKim Ra Gyung, Cho Jongwook, Park Ji-Young, Kim Young Ro, Lee Min-Cheol, Kim Hyoung-Ihlpp. 1-11
원문 보기